Multicenter long-term results of antitachycardia pacing for supraventricular tachycardias

Details

Serval ID
serval:BIB_B1EEC2DF2CBB
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Multicenter long-term results of antitachycardia pacing for supraventricular tachycardias
Journal
American Journal of Cardiology
Author(s)
Kappenberger  L., Valin  H., Sowton  E.
ISSN
0002-9149 (Print)
Publication state
Published
Issued date
07/1989
Volume
64
Number
3
Pages
191-3
Notes
Clinical Trial
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't --- Old month value: Jul 15
Abstract
This report describes the multicenter experience of the Tachylog antitachycardia pacemaker (Siemens-Elema) in the treatment of drug-refractory, recurrent supraventricular arrhythmias. The device has been implanted in 63 patients (mean age 47 years). The arrhythmias were atrial tachycardia in 4 patients (6%), atrioventricular nodal reentry tachycardia in 23 patients (37%), circus movement tachycardia via an overt bypass tract in 17 patients (27%) and via a concealed bypass tract in 19 patients (30%). The mean follow-up period was 30 months. In 28 patients (44%) arrhythmia control was achieved with the pacemaker therapy alone. In 31 patients (49%) drug therapy had to be reintroduced to obtain control of recurrent arrhythmias. Four patients (6%) were definite nonresponders. In 4 patients (6%) the pulse generator was explanted either because it was not tolerated or because of tachycardia-sensing failure. No syncope or death was observed during follow-up. Thus, antitachycardia pacing gives satisfactory results in selected patients with drug-refractory supraventricular tachycardias.
Keywords
*Cardiac Pacing, Artificial Follow-Up Studies Humans Middle Aged Multicenter Studies Recurrence Tachycardia, Supraventricular/*therapy
Pubmed
Web of science
Create date
15/02/2008 12:29
Last modification date
20/08/2019 16:20
Usage data